Stock 688276 CHANGCHUN BCHT BIOTECHNOLOGY CO.
Add to a list
To use this feature you must be a member
Log inSign up

Company Changchun BCHT Biotechnology Co.

Equities

688276

CNE100005XY6

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-06 pm EDT 		5-day change 1st Jan Change
41.17 CNY +0.32% Intraday chart for Changchun BCHT Biotechnology Co. +5.37% -24.89%
Apr. 24 Chinese Drug Regulator Accepts BCHT Biotechnology's Marketing Application for Influenza Nasal Spray Vaccine MT
Apr. 19 Changchun BCHT Biotechnology Co. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Changchun BCHT Biotechnology Co is a China-based innovative biomedical company mainly dedicated to the prevention and treatment of infectious diseases. The Company is mainly engaged in the research and development, production and sales of human vaccines. The Company has three approved vaccine products: varicella vaccine, rabies vaccine and freeze-dried nasal spray flu vaccine. The Company also has other vaccines under development and fully human monoclonal antibody under development for the prevention and control of infectious diseases. The Company mainly conducts business within the domestic market.

Number of employees: 1,241

Sales per Business

CNY in Million2022Weight2023Weight Delta
Shingles Vaccine
48.4 %
- - 883 48.4 % -
Chickenpox Vaccine
44.9 %
957 89.4 % 820 44.9 % -14.36%
Nasal Spray Flu Vaccine
6.7 %
114 10.6 % 122 6.7 % +6.85%
Other Business
0.0 %
0 0.0 % 0 0.0 % +193.12%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
98.1 %
1,051 98.1 % 1,789 98.1 % +70.22%
Abroad
1.9 %
20 1.9 % 35 1.9 % +74.43%

Managers

Managers TitleAgeSince
Wei Kong CEO
 Chief Executive Officer 59 03-12-31
Zhao Feng Meng DFI
 Director of Finance/CFO 60 19-01-31
Da Qiang Feng CHM
 Chairman 58 04-02-29
Chang Lin Zhu CTO
 Chief Tech/Sci/R&D Officer 56 03-12-31
Chun Lai Jiang BRD
 Director/Board Member 51 09-06-30
Xiu Feng Li BRD
 Director/Board Member 55 04-02-29
Xue Lian Tong IRC
 Investor Relations Contact 34 16-12-31
Zhe Zhang IRO
 Public Communications Contact 49 03-12-31

Members of the board

Members of the board TitleAgeSince
Xiu Feng Li BRD
 Director/Board Member 55 04-02-29
Xing Gong Zhu BRD
 Director/Board Member 57 21-08-02
De Shen Zhang BRD
 Director/Board Member 60 19-02-20
Ji Ma CHM
 Chairman 59 21-07-08
Yun Tao Jiang BRD
 Director/Board Member 50 18-06-30
Wei Kong CEO
 Chief Executive Officer 59 03-12-31
Chun Lai Jiang BRD
 Director/Board Member 51 09-06-30
Jing Liu BRD
 Director/Board Member 62 20-05-31
Da Yong Xu BRD
 Director/Board Member 60 20-06-18
Da Qiang Feng CHM
 Chairman 58 04-02-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 413,657,598 89,155,673 ( 21.55 %) 0 21.55 %

Shareholders

NameEquities%Valuation
Wei Kong
43.01 %
104,448,497 43.01 % 641 M ¥
Xue Ning Wei
8.629 %
20,954,688 8.629 % 129 M ¥
China Merchants Fund Management Co., Ltd.
2.541 %
6,169,571 2.541 % 38 M ¥
Xiao Hui Chen
2.466 %
5,987,472 2.466 % 37 M ¥
Shang Shu Hu
2.100 %
5,100,000 2.100 % 31 M ¥
Sheng Yu
1.705 %
4,140,000 1.705 % 25 M ¥
National Social Security Fund Portfolio 118
1.701 %
4,130,787 1.701 % 25 M ¥
Hong Wang
1.343 %
3,260,095 1.343 % 20 M ¥
City of Changchun
1.192 %
2,895,124 1.192 % 18 M ¥
Huashang Fund Management Co., Ltd.
1.003 %
2,436,436 1.003 % 15 M ¥

Company contact information

Changchun BCHT Biotechnology Co.

138, Zhuoyue Street Chaoyang District

130103, Changchun

+86 431 8187 1520

http://www.bchtpharm.com
address Changchun BCHT Biotechnology Co.(688276)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Sales per region

Ratings for Changchun BCHT Biotechnology Co.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
41.17 CNY
Average target price
54.56 CNY
Spread / Average Target
+32.54%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-24.89% 2.36B
MERCK KGAA Stock Merck KGaA
+6.52% 71.18B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+12.74% 9.23B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-11.55% 5B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+48.05% 4.46B
YUHAN CORPORATION Stock Yuhan Corporation
+5.09% 3.95B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-14.74% 2.54B
INDIVIOR PLC Stock Indivior PLC
+20.00% 2.44B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+21.45% 2.18B
SUPERNUS PHARMACEUTICALS, INC. Stock Supernus Pharmaceuticals, Inc.
+7.64% 1.67B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 688276 Stock
  4. Company Changchun BCHT Biotechnology Co.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW